1. PFE:NYQ

    Pfizer Inc

    USD

    31.65

    Today's change

    0.23 / +0.73%

    1 year change

    +3.60%

    As of Dec 26 2014 21:00 GMT. Data delayed by at least 15 minutes.

Search for Pfizer Inc and
  1. 24 hours ago

    Big pharma cashes in as M&A fever sweeps sector

    It was a big year for big pharma as a succession of multibillion-dollar mergers and acquisitions swept the industry. More...

  2. December 22, 2014

    Takeover volumes move to highest post-crisis levels

    Corporate takeover deals surged to their highest levels since the financial crisis this year, with merger and acquisition...

Special Reports

  1. Combating Cancer

    A wave of drugs that harnesses the body’s immune system is fuelling optimism that scie...
  2. Combating Neglected Diseases

    While nobody questions the horror of the Ebola epidemic sweeping west Africa, the deat...
Search more Special Reports on this topic.

  1. December 10, 2014

    India assumes frontline position in battles over intellectual property rights

    As their cities grow more polluted, more people in India grapple with respiratory difficulties. The Swiss multinational...

  2. December 10, 2014

    Fraudsters’ robots to cost marketers $6bn

    Marketers will lose $6bn next year to fraudsters who are using networks of robots to exploit the online advertising...

  3. December 9, 2014

    Tax deals raise questions over Ireland’s growth spurt

    Four years after entering a punishing €67bn bailout, the Irish economy is booming again. Gross domestic product expanded at...

  4. December 1, 2014

    ‘Milestone’ in fight against Aids as treatment outpaces infections

    The world has passed an important tipping point in the fight against Aids, according to data showing that more people gained...

  5. November 28, 2014

    How to invest in petcare

    Keeping animals can be a notoriously expensive whim. Beyond the regular costs of feeding a pet are the unexpected veterinary...

  6. November 25, 2014

    AstraZeneca comes into focus as Pfizer’s cooling-off period ends

    It has been a popular pastime among healthcare investors and pharma executives for weeks: guessing the likelihood of Pfizer...

  7. November 18, 2014

    AstraZeneca fleshes out standalone strategy

    AstraZeneca championed its prospects as a standalone company on Tuesday as it gave more details of its strategy to investors...

  8. November 11, 2014

    Ackman-led team takes 10% stake in Zoetis

    The activist investor Bill Ackman is leading a $2.2bn raid on Zoetis, the animal vaccines and medications business spun off...

  9. November 6, 2014

    AstraZeneca: priorities

    $4.20. This little number probably takes up quite a bit of space in the minds of executives at AstraZeneca. Azip, one of the...

  10. November 6, 2014

    AstraZeneca aims to ward off Pfizer by highlighting ‘tax inversion’ risks

    AstraZeneca sought to ward off Pfizer from making a fresh approach for the UK drugmaker by highlighting the increased risk...

  11. November 4, 2014

    Ackman gains ground in fight to force Allergan to sell to Valeant

    Bill Ackman chalked up a big victory in his battle to force Allergan, the maker of blockbuster wrinkle treatment Botox, to...

  12. October 28, 2014

    Pfizer chief: tax inversions still have ‘meaningful value’

    Pfizer has said there is still “meaningful value” to be found in tax inversions despite a White House crackdown that has...

  13. October 24, 2014

    Bellwether UPS rises on ecommerce hopes

    Investors liked what they heard from parcel delivery company and US economic bellwether UPS, which beat third-quarter...

  14. October 24, 2014

    Shire and AstraZeneca show standalone strength

    Britain’s number two and three drugmakers burnished their strength as independent companies on Friday when Shire reported...

  15. October 23, 2014

    Industry response to Ebola quickens

    Pharmaceutical executives and international donors were thrashing out details of a push to accelerate development of...

  16. October 21, 2014

    Technology, tax and talent in Dublin

    Dozens of giant light-sticks illuminate the path to Dublin’s Grand Canal Theatre at night, glowing red and flashing in...

  17. October 17, 2014

    Pfizer’s AstraZeneca pursuit knocked by Shire deal collapse

    The chances of Pfizer reviving its pursuit of AstraZeneca have been greatly diminished after the collapse of AbbVie’s £32bn...

  18. October 16, 2014

    Pharma giants face developing market ambitions

    As the pharmaceuticals industry careered towards the edge of its notorious patent cliff over the past decade, there was one...

  19. October 13, 2014

    Renewed merger hopes boost AstraZeneca

    Refreshed hopes of another approach from Pfizer put AstraZeneca back in demand on Monday. AstraZeneca has slipped over the...

  20. October 9, 2014

    Environmental and educational efforts lead assault on trachoma

    Some diseases are devastating because of their symptoms, some because of their outcome. Blinding trachoma is both:...

  21. September 28, 2014

    Drugs groups trapped in tangled M&A web

    When Valeant offered almost $46bn to buy Allergan in April, it seemed like a large but relatively straightforward deal....

  22. September 26, 2014

    Drug development: Big pharma back in the game it made

    Big pharma is back. That, at least, is the impression created by a wave of new cancer drugs rapidly approaching market....

  23. September 26, 2014

    Battling cancer: Focus turns to defence as best form of attack

    It has been described as the beginning of the end of cancer. A new wave of drugs that harnesses the body’s immune system to...

  24. September 23, 2014

    Curbs on tax inversions fail to convince

    Dissections of a White House plan to curb tax-driven mergers gave way on Tuesday to a realisation that the most significant...

  25. September 23, 2014

    CarMax sputters on disappointing sales

    Shares of CarMax, the largest US used auto dealer, declined on Tuesday after same-store sales nearly flatlined and earnings...

  26. September 23, 2014

    US Treasury hopes to stand logic of tax inversion deals on head

    Taxes may be one of the only two certainties, but tax benefits are very uncertain – as the US Treasury has just...

  27. September 23, 2014

    London stocks hit by US tax crackdown

    London’s equity markets were lower for a second session this week, with drugmakers leading losses after US authorities...

  28. September 15, 2014

    Takeover Panel proposes tougher rules for deal promises

    The body that polices UK dealmaking has proposed strengthening its governing Takeover Code to address promises made during...

  29. September 11, 2014

    Pfizer says ‘window still open’ for tax inversions

    Pfizer says the window is still open for US companies to use transatlantic deals to lower their tax rates despite President...

  30. August 29, 2014

    AstraZeneca gains on renewed bid chatter

    AstraZeneca was among the FTSE 100 leaders on Friday as bid chatter continued to prod the drug company’s shares higher. The...

  31. August 28, 2014

    Douglas Carswell in quotes

    Tory MP Douglas Carswell, who defected to the anti-Brussels, anti-immigration UK Independence party on Thursday, is a...

  32. August 24, 2014

    Pfizer weighs options on AstraZeneca bid

    Pfizer is considering its acquisition options as a potential path opens this week for the US drugmaker to renew its pursuit...

  33. August 21, 2014

    Drugmaker link-up puts Astra on top

    The UK’s two biggest drugmakers both made it on to the FTSE 100 leaderboard after AstraZeneca developed a partnership that...

  34. August 6, 2014

    Pharma shares slide on fears of ‘tax inversion’ clampdown

    Investors fled global healthcare stocks on Wednesday after the Obama administration threatened action to halt the wave of...

  35. August 4, 2014

    AstraZeneca chairman Leif Johansson defends Pfizer rebuff

    Leif Johansson wants to set something straight: he does not want to be prime minister of Sweden. This was just one of the...

  36. August 1, 2014

    GlaxoSmithKline vulnerable to Pfizer bid after price slump

    GlaxoSmithKline’s fall to an 18-month low might make the drugmaker vulnerable, according to Berenberg analysts. A 20 per...

  37. July 31, 2014

    AstraZeneca raises full-year earnings guidance

    AstraZeneca raised its full-year earnings guidance on Thursday as Pascal Soriot, chief executive, declared “significant...

  38. July 30, 2014

    AstraZeneca to bolster respiratory drugs with Almirall deal

    AstraZeneca has bought a range of respiratory drugs from Almirall of Spain for up to $2.1bn in its biggest deal since...

Search for Pfizer Inc and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Lex on the rejection of Pfizer's ‘final’ bid...
    May 19, 2014

    Lex on the rejection of Pfizer's ‘final’ bid

  2. The FT debates Pfizer's takeover bid for AstraZeneca...
    May 13, 2014

    The FT debates Pfizer's takeover bid for AstraZeneca